GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » Beneish M-Score

Hanmi Science Co (XKRX:008930) Beneish M-Score : -2.24 (As of May. 06, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Hanmi Science Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.24 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Hanmi Science Co's Beneish M-Score or its related term are showing as below:

XKRX:008930' s Beneish M-Score Range Over the Past 10 Years
Min: -5.33   Med: -2.31   Max: 2.09
Current: -2.24

During the past 13 years, the highest Beneish M-Score of Hanmi Science Co was 2.09. The lowest was -5.33. And the median was -2.31.


Hanmi Science Co Beneish M-Score Historical Data

The historical data trend for Hanmi Science Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Science Co Beneish M-Score Chart

Hanmi Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.50 -2.46 -5.33 -1.58 -2.24

Hanmi Science Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.58 -1.67 -1.21 -1.25 -2.24

Competitive Comparison of Hanmi Science Co's Beneish M-Score

For the Medical Distribution subindustry, Hanmi Science Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanmi Science Co's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hanmi Science Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Hanmi Science Co's Beneish M-Score falls into.



Hanmi Science Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Hanmi Science Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8292+0.528 * 0.9404+0.404 * 1.0016+0.892 * 1.193+0.115 * 0.6832
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0183+4.679 * 0.065214-0.327 * 1.0373
=-2.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₩108,693 Mil.
Revenue was 331929.7 + 309356.996 + 315356.702 + 291262.98 = ₩1,247,906 Mil.
Gross Profit was 74284.066 + 309356.996 + 315356.702 + 61331.826 = ₩760,330 Mil.
Total Current Assets was ₩273,900 Mil.
Total Assets was ₩1,226,170 Mil.
Property, Plant and Equipment(Net PPE) was ₩94,068 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩8,732 Mil.
Selling, General, & Admin. Expense(SGA) was ₩650,728 Mil.
Total Current Liabilities was ₩395,202 Mil.
Long-Term Debt & Capital Lease Obligation was ₩10,769 Mil.
Net Income was 34572.376 + 30794.556 + 23036.367 + 26718.213 = ₩115,122 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was -4973.56 + 16581.324 + 13232.436 + 10318.06 = ₩35,158 Mil.
Total Receivables was ₩109,872 Mil.
Revenue was 288125.227 + 251893.899 + 254079.309 + 251955.776 = ₩1,046,054 Mil.
Gross Profit was 56803.383 + 251893.899 + 254079.309 + 36579.137 = ₩599,356 Mil.
Total Current Assets was ₩245,348 Mil.
Total Assets was ₩1,109,691 Mil.
Property, Plant and Equipment(Net PPE) was ₩88,919 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩5,478 Mil.
Selling, General, & Admin. Expense(SGA) was ₩535,650 Mil.
Total Current Liabilities was ₩347,726 Mil.
Long-Term Debt & Capital Lease Obligation was ₩6,483 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(108693.129 / 1247906.378) / (109871.847 / 1046054.211)
=0.0871 / 0.105035
=0.8292

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(599355.728 / 1046054.211) / (760329.59 / 1247906.378)
=0.572968 / 0.609284
=0.9404

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (273900.397 + 94068.246) / 1226170.046) / (1 - (245348.144 + 88919.154) / 1109690.934)
=0.699904 / 0.698774
=1.0016

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1247906.378 / 1046054.211
=1.193

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(5478.448 / (5478.448 + 88919.154)) / (8732.38 / (8732.38 + 94068.246))
=0.058036 / 0.084945
=0.6832

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(650727.68 / 1247906.378) / (535650.028 / 1046054.211)
=0.521456 / 0.512067
=1.0183

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10768.617 + 395202.032) / 1226170.046) / ((6482.622 + 347726.499) / 1109690.934)
=0.331088 / 0.319196
=1.0373

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(115121.512 - 0 - 35158.26) / 1226170.046
=0.065214

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Hanmi Science Co has a M-score of -2.24 suggests that the company is unlikely to be a manipulator.


Hanmi Science Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Hanmi Science Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Science Co (XKRX:008930) Business Description

Traded in Other Exchanges
N/A
Address
214 Muha-ro Paltan-myeon, Gyeonggi-do, Hwaseong, KOR
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.

Hanmi Science Co (XKRX:008930) Headlines

No Headlines